Pneumonia News and Research

Latest Pneumonia News and Research

Binghamton University plays role in improving Rwandan’s healthcare system

Twenty years after the Rwandan Genocide left nearly 1 million dead and 2 million homeless, Binghamton University is playing a role in improving the nation's healthcare. Karen Feltham, a clinical instructor in the Decker School of Nursing, spent the 2013 fall semester in Rwanda working with women in the Rwandan Midwives Association.

17 Mar 2014

Viewpoints: The impact of Florida's special election; drug testing for doctors; the toll from Alzheimer's

A rule of electoral politics is that when a Democratic wave is building, the media broadcast it like a foregone conclusion. When a Republican wave is building, Beltway pundits are the last to admit it. After Tuesday's GOP win in a Florida special House election, even the press corps now agrees that Republicans are poised for major gains in November, assuming the GOP has the wit to exploit it (3/12).

14 Mar 2014

Australians it's time to consider a flu vaccination

Although it is still early in the season, NPS MedicineWise is joining other health experts in recommending that people at risk of complications of the flu (influenza) get vaccinated against the illness.

13 Mar 2014

TFDA approves TaiGen's Taigexyn NDA for treatment of community-acquired bacterial pneumonia

TaiGen Biotechnology Company, Limited today announced that the Taiwan Food and Drug Administration has approved the new drug application (NDA) of Taigexyn (nemonoxacin) oral formulation (500 mg) for the treatment of community-acquired bacterial pneumonia (CAP). With this NDA approval, Taiwan is the first region to grant marketing approval to Taigexyn.

13 Mar 2014

New research raises hopes of new class of drugs to combat antibiotic resistant infections

New research has found some compounds effective in blocking the proliferation of certain bacteria, raising hopes of a new class of drugs to combat antibiotic resistant infections

13 Mar 2014

Researchers suggest potential treatment target for HCMV infection

Discovering where a common virus hides in the body has been a long-term quest for scientists. Up to 80 percent of adults harbor the human cytomegalovirus (HCMV), which can cause severe illness and death in people with weakened immune systems.

11 Mar 2014

Sleep apnoea may be risk factor for pneumonia

People who suffer from sleep apnoea face an increased risk of developing pneumonia, a large epidemiological study indicates.

10 Mar 2014

Scientists uncover bacterial secretion system that allows sharing of genetic material between bacteria

The system that allows the sharing of genetic material between bacteria - and therefore the spread of antibiotic resistance - has been uncovered by a team of scientists at Birkbeck, University of London and UCL.

10 Mar 2014

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Tetraphase Pharmaceuticals, Inc. today reported financial results for the quarter and full year ended December 31, 2013.

6 Mar 2014

Alzheimer's disease may contribute to close to as many deaths as heart disease

A new study suggests that Alzheimer's disease may contribute to close to as many deaths in the United States as heart disease or cancer. The research is published in the March 5, 2014, print issue of Neurology®, the medical journal of the American Academy of Neurology.

6 Mar 2014

People with sleep apnea appear to be at increased risk of pneumonia

People with sleep apnea appear to be at higher risk of pneumonia than people without, according to a study published in CMAJ (Canadian Medical Association Journal).

4 Mar 2014

Scientists map key elements of immune overreaction triggered by influenza virus infection

Scientists at The Scripps Research Institute (TSRI) have mapped key elements of a severe immune overreaction—a "cytokine storm"—that can both sicken and kill patients who are infected with certain strains of flu virus.

3 Mar 2014

TSRI scientists describe severe immune overreaction caused by flu infections

Scientists at The Scripps Research Institute have mapped key elements of a severe immune overreaction—a “cytokine storm”—that can both sicken and kill patients who are infected with certain strains of flu virus.

28 Feb 2014

S. pneumoniae highly prevalent in urban Indonesians, especially children

Streptococcus pneumoniae is present in the nasopharyngeal mucosa in nearly half of children under the age of 5 years and one in 10 adults living in Java Island, Indonesia, a survey has found.

25 Feb 2014

Isis Pharmaceuticals provides update on ISIS-SMNRx Phase 2 study in infants with SMA

Isis Pharmaceuticals, Inc. today provided an update on its ongoing open label, multiple dose Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy (SMA).

25 Feb 2014

Researchers identify novel strategies to develop more efficient vaccines against encapsulated bacteria

Researchers have discovered the presence of a novel subtype of innate lymphoid cells in human spleen essential for the production of antibodies. This discovery, published in the prestigious journal Nature Immunology, clears the path to the identification of novel strategies to develop more efficient vaccines against encapsulated bacteria, considered highly virulent.

24 Feb 2014

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Pharmacyclics, Inc. today reported financial results and recent developments for the quarter and year ended December 31, 2013.

20 Feb 2014

Research shows that seasonal flu vaccination may reduce risk of stroke

Having the seasonal flu jab could reduce the risk of suffering a stroke by almost a quarter, researchers have found.

20 Feb 2014

Idiopathic pulmonary fibrosis could soon be diagnosed without the need for surgical lung biopsy

People who have suspected idiopathic pulmonary fibrosis without typical patterns on high resolution computed tomography scans could in future be spared the substantial risks of lung biopsy and be given a confident diagnosis of IPF based on clinical and radiological findings alone, according to new research published in The Lancet Respiratory Medicine.

20 Feb 2014

Nintedanib plus docetaxel shows second-line efficacy in recurrent NSCLC

Nintedanib plus docetaxel offers significant efficacy in patients with non-small-cell lung cancer who experience disease progression after first-line chemotherapy, phase III study results show.

19 Feb 2014

Pneumonia News and Research

Latest Pneumonia News and Research

Binghamton University plays role in improving Rwandan’s healthcare system

Viewpoints: The impact of Florida's special election; drug testing for doctors; the toll from Alzheimer's

Australians it's time to consider a flu vaccination

TFDA approves TaiGen's Taigexyn NDA for treatment of community-acquired bacterial pneumonia

New research raises hopes of new class of drugs to combat antibiotic resistant infections

Researchers suggest potential treatment target for HCMV infection

Sleep apnoea may be risk factor for pneumonia

Scientists uncover bacterial secretion system that allows sharing of genetic material between bacteria

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Alzheimer's disease may contribute to close to as many deaths as heart disease

People with sleep apnea appear to be at increased risk of pneumonia

Scientists map key elements of immune overreaction triggered by influenza virus infection

TSRI scientists describe severe immune overreaction caused by flu infections

S. pneumoniae highly prevalent in urban Indonesians, especially children

Isis Pharmaceuticals provides update on ISIS-SMNRx Phase 2 study in infants with SMA

Researchers identify novel strategies to develop more efficient vaccines against encapsulated bacteria

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Research shows that seasonal flu vaccination may reduce risk of stroke

Idiopathic pulmonary fibrosis could soon be diagnosed without the need for surgical lung biopsy

Nintedanib plus docetaxel shows second-line efficacy in recurrent NSCLC

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Pneumonia News and Research

Latest Pneumonia News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in